{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:44:41Z","timestamp":1791585881693,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82471971"],"award-info":[{"award-number":["No. 82471971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Liaoning Province Science and Technology Joint Plan","award":["2023JH2\/101700127"],"award-info":[{"award-number":["2023JH2\/101700127"]}]},{"name":"the Leading Young Talent Program of Xingliao Yingcai in Liaoning Province","award":["XLYC2203037"],"award-info":[{"award-number":["XLYC2203037"]}]},{"name":"Liaoning Provincial Science and Technology Program","award":["2025-BS-0581"],"award-info":[{"award-number":["2025-BS-0581"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00535-026-02346-z","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:33:22Z","timestamp":1770136402000},"page":"496-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["YAP1-driven tumor-like cancer-associated fibroblasts modulate biomechanics of pancreatic ductal adenocarcinoma"],"prefix":"10.1007","volume":"61","author":[{"given":"Aoran","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihe","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, et al. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840. https:\/\/doi.org\/10.1126\/scitranslmed.adg3840.","journal-title":"Sci Transl Med"},{"key":"2346_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov. 2024;14:1375\u201388. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0002.","journal-title":"Cancer Discov"},{"key":"2346_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11:5120. https:\/\/doi.org\/10.1038\/s41467-020-18794-x.","journal-title":"Nat Commun"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"2346_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, et al. Pancreatic cancer. Lancet. 2025;405:1182\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(25)00261-2.","journal-title":"Lancet"},{"key":"2346_CR6","doi-asserted-by":"publisher","first-page":"19609","DOI":"10.1073\/pnas.1908626116","volume":"116","author":"C Tian","year":"2019","unstructured":"Tian C, et al. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells. Proc Natl Acad Sci U S A. 2019;116:19609\u201318. https:\/\/doi.org\/10.1073\/pnas.1908626116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2346_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188356","volume":"1873","author":"B Piersma","year":"2020","unstructured":"Piersma B, Hayward M-K, Weaver VM. Fibrosis and cancer: a strained relationship. Biochim Biophys Acta (BBA) Rev Cancer. 2020;1873:188356. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188356.","journal-title":"Biochim Biophys Acta (BBA) Rev Cancer"},{"key":"2346_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.trecan.2023.07.006","volume":"9","author":"M Kalli","year":"2023","unstructured":"Kalli M, Poskus MD, Stylianopoulos T, Zervantonakis IK. Beyond matrix stiffness: targeting force-induced cancer drug resistance. Trends Cancer. 2023;9:937\u201354. https:\/\/doi.org\/10.1016\/j.trecan.2023.07.006.","journal-title":"Trends Cancer"},{"key":"2346_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"key":"2346_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, et al. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15:34. https:\/\/doi.org\/10.1186\/s13045-022-01252-0.","journal-title":"J Hematol Oncol"},{"key":"2346_CR11","doi-asserted-by":"publisher","first-page":"9713","DOI":"10.1021\/acsnano.4c01499","volume":"18","author":"Z-W Qiu","year":"2024","unstructured":"Qiu Z-W, et al. Breaking physical barrier of fibrotic breast cancer for photodynamic immunotherapy by remodeling tumor extracellular matrix and reprogramming cancer-associated fibroblasts. ACS Nano. 2024;18:9713\u201335. https:\/\/doi.org\/10.1021\/acsnano.4c01499.","journal-title":"ACS Nano"},{"key":"2346_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.05.005","author":"Y Shen","year":"2020","unstructured":"Shen Y, et al. Reduction of liver metastasis stiffness improves response to Bevacizumab in metastatic colorectal cancer. Cancer Cell. 2020. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.005.","journal-title":"Cancer Cell"},{"key":"2346_CR13","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.15252\/embr.201540107","volume":"16","author":"CD Madsen","year":"2015","unstructured":"Madsen CD, et al. Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis. EMBO Rep. 2015;16:1394\u2013408. https:\/\/doi.org\/10.15252\/embr.201540107.","journal-title":"EMBO Rep"},{"key":"2346_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci O, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020;11:2416. https:\/\/doi.org\/10.1038\/s41467-020-16199-4.","journal-title":"Nat Commun"},{"key":"2346_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.canlet.2019.07.015","volume":"462","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, et al. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation. Cancer Lett. 2019;462:51\u201360. https:\/\/doi.org\/10.1016\/j.canlet.2019.07.015.","journal-title":"Cancer Lett"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/1878-0261.13442","volume":"17","author":"Y-T Chang","year":"2023","unstructured":"Chang Y-T, et al. Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways. Mol Oncol. 2023;17:1628\u201347. https:\/\/doi.org\/10.1002\/1878-0261.13442.","journal-title":"Mol Oncol"},{"key":"2346_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/path.6033","volume":"259","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways. J Pathol. 2023;259:205\u201319. https:\/\/doi.org\/10.1002\/path.6033.","journal-title":"J Pathol"},{"key":"2346_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1481","volume":"13","author":"B Chen","year":"2023","unstructured":"Chen B, et al. H. pylori-induced NF-\u03baB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. Clin Transl Med. 2023;13:e1481. https:\/\/doi.org\/10.1002\/ctm2.1481.","journal-title":"Clin Transl Med"},{"key":"2346_CR19","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.3748\/wjg.v19.i37.6284","volume":"19","author":"X Li","year":"2013","unstructured":"Li X, Xu W, Shi J, Lin Y, Zeng X. Endoscopic ultrasound elastography for differentiating between pancreatic adenocarcinoma and inflammatory masses: a meta-analysis. World J Gastroenterol. 2013;19:6284\u201391. https:\/\/doi.org\/10.3748\/wjg.v19.i37.6284.","journal-title":"World J Gastroenterol"},{"key":"2346_CR20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.231220","volume":"310","author":"G Moura Cunha","year":"2024","unstructured":"Moura Cunha G, et al. Interpretation, reporting, and clinical applications of liver MR elastography. Radiology. 2024;310:e231220. https:\/\/doi.org\/10.1148\/radiol.231220.","journal-title":"Radiology"},{"key":"2346_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110360","volume":"152","author":"TJ Vogl","year":"2022","unstructured":"Vogl TJ, Dosch MP, Haas Y. MR elastography is a good response parameter for microwave ablation liver tumors. Eur J Radiol. 2022;152:110360. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110360.","journal-title":"Eur J Radiol"},{"key":"2346_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03297-8","volume":"44","author":"K Wang","year":"2025","unstructured":"Wang K, et al. Extracellular matrix stiffness regulates colorectal cancer progression via HSF4. J Exp Clin Cancer Res. 2025;44:30. https:\/\/doi.org\/10.1186\/s13046-025-03297-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"2346_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3174\/ajnr.A5415","volume":"39","author":"KM Pepin","year":"2018","unstructured":"Pepin KM, et al. MR elastography analysis of glioma stiffness and IDH1-mutation status. AJNR Am J Neuroradiol. 2018;39:31\u20136. https:\/\/doi.org\/10.3174\/ajnr.A5415.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-023-00614-y","volume":"4","author":"JL Chitty","year":"2023","unstructured":"Chitty JL, et al. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nat Cancer. 2023;4:1326\u201344. https:\/\/doi.org\/10.1038\/s43018-023-00614-y.","journal-title":"Nat Cancer"},{"key":"2346_CR25","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1038\/s41388-023-02844-x","volume":"42","author":"Y Xin","year":"2023","unstructured":"Xin Y, et al. Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine. Oncogene. 2023;42:3457\u201390. https:\/\/doi.org\/10.1038\/s41388-023-02844-x.","journal-title":"Oncogene"},{"key":"2346_CR26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro A, Panciera T, Piccolo S. YAP\/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20:888\u201399. https:\/\/doi.org\/10.1038\/s41556-018-0142-z.","journal-title":"Nat Cell Biol"},{"key":"2346_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383. https:\/\/doi.org\/10.1038\/nature10137.","journal-title":"Nature"},{"key":"2346_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.008","author":"A Elosegui-Artola","year":"2017","unstructured":"Elosegui-Artola A, et al. Force triggers YAP nuclear entry by regulating transport across nuclear pores. Cell. 2017. https:\/\/doi.org\/10.1016\/j.cell.2017.10.008.","journal-title":"Cell"},{"key":"2346_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15:637\u201346. https:\/\/doi.org\/10.1038\/ncb2756.","journal-title":"Nat Cell Biol"},{"key":"2346_CR30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, de Souza N, Bodenmiller B. Classifying cancer-associated fibroblasts-the good, the bad, and the target. Cancer Cell. 2024;42:1480\u20135. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.011.","journal-title":"Cancer Cell"},{"key":"2346_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45595-3","volume":"15","author":"M Licaj","year":"2024","unstructured":"Licaj M, et al. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nat Commun. 2024;15:1312.","journal-title":"Nat Commun"},{"key":"2346_CR32","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1158\/0008-5472.CAN-23-3933","volume":"84","author":"M Park","year":"2024","unstructured":"Park M, et al. Targeting YAP activity and glutamine metabolism cooperatively suppresses tumor progression by preventing extracellular matrix accumulation. Cancer Res. 2024;84:3388\u2013401.","journal-title":"Cancer Res"},{"key":"2346_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719\u201334.","journal-title":"Cancer Cell"},{"key":"2346_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.12.021","author":"L Cords","year":"2024","unstructured":"Cords L, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.021.","journal-title":"Cancer Cell"},{"key":"2346_CR35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccell.2015.11.002","volume":"28","author":"BC \u00d6zdemir","year":"2015","unstructured":"\u00d6zdemir BC, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2015;28:831\u20133.","journal-title":"Cancer Cell"},{"key":"2346_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33688-w","volume":"13","author":"SB Kokate","year":"2022","unstructured":"Kokate SB, et al. Caldesmon controls stress fiber force-balance through dynamic cross-linking of myosin II and actin-tropomyosin filaments. Nat Commun. 2022;13:6032.","journal-title":"Nat Commun"},{"key":"2346_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021135118","author":"RS Fischer","year":"2021","unstructured":"Fischer RS, et al. Contractility, focal adhesion orientation, and stress fiber orientation drive cancer cell polarity and migration along wavy ECM substrates. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2021135118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2346_CR38","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.7150\/thno.74563","volume":"12","author":"P Yue","year":"2022","unstructured":"Yue P, et al. Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload. Theranostics. 2022;12:7009\u201331.","journal-title":"Theranostics"},{"key":"2346_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46467-4","volume":"13","author":"N Hoeffner","year":"2023","unstructured":"Hoeffner N, Paul A, Goo Y-H. Drug screen identifies verteporfin as a regulator of lipid metabolism in macrophage foam cells. Sci Rep. 2023;13:19588.","journal-title":"Sci Rep"},{"key":"2346_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.freeradbiomed.2022.10.323","volume":"193","author":"S Li","year":"2022","unstructured":"Li S, et al. YAP1 silencing attenuated lung injury\/fibrosis but worsened diaphragmatic function by regulating oxidative stress and inflammation response in mice. Free Radic Biol Med. 2022;193:485\u201398.","journal-title":"Free Radic Biol Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02346-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:50:59Z","timestamp":1775213459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02346-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02346-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is a prospective single-center clinical trial, which has been registered in the U.S. Clinical Trials Database (\n                      \n                      ) with the trial registration number NCT06526442. The registration date was October 9th, 2020. This study was complied with the Health Insurance Portability and Accountability Act and was approved by the Institutional Review Board (IRB) of Shengjing Hospital of China Medical University (Human Research Ethics Committee approval 2022PS1006K and 2022PS1006K(T2)), with written informed consent obtained from all participants. Patients were recruited between Jan 2022 and Oct 2025. For mice, all of the protocols were followed the guidelines of the Institutional Animal Care and Use Committee (IACUC), and were approved by the Medical Ethics Committee of our local hospital (approval number 2023PS1082K).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}